What quality‑assurance metrics best assess the diagnostic performance of pathologists in thyroid fine‑needle aspiration cytology?
Cancer Cytopathology · 2026-05 · 134 (5)
DOI: 10.1002/cncy.70101 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Cytopathology, online erschienen am 25.04.2026. Verfasst von Tarik M Elsheikh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
We thank Dr Renshaw for his interest in our recent publication regarding the use of molecular testing and other metrics as quality - assurance measures in assessing the performance of pathologists in diagnosing thyroid cytology. 1 He raises an interesting hypothesis: in the era of reflex molecular testing, higher atypia of undetermined significance (AUS) rates may be associated with better detection of malignancy across cytologic diagnoses of AUS and higher (AUS + ) while also being associated with minimal increased surgery rate for benign disease (unnecessary surgery). His hypothesis was based on re - analysis of our data from Table 1 and subgrouping pathologists into low - AUS (nine pathologists; AUS range, 7.2%–17.2%) and high - AUS (six pathologists; AUS range 18.8%–40.6%) groups. According to his analysis, the high - AUS group was associated with 23% better detection of malignancy, and only 2% of additional patients underwent unnecessary surgery compared with the low - AUS group.
Autor:innen und Institutionen
- Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Tarik M Elsheikh, Erika E Doxtader
Zitieren
APA
Elsheikh, T. M., Doxtader, E. E., & Chaari, R. (2026). What quality‑assurance metrics best assess the diagnostic performance of pathologists in thyroid fine‑needle aspiration cytology?. Cancer Cytopathology, 134(5). https://doi.org/10.1002/cncy.70101
Vancouver
Elsheikh TM, Doxtader EE, Chaari R. What quality‑assurance metrics best assess the diagnostic performance of pathologists in thyroid fine‑needle aspiration cytology?. Cancer Cytopathology. 2026;134(5). doi:10.1002/cncy.70101
BibTeX
@article{Elsheikh2026,
author = {Elsheikh, Tarik M and Doxtader, Erika E and Chaari, Rema},
title = {What quality‑assurance metrics best assess the diagnostic performance of pathologists in thyroid fine‑needle aspiration cytology?},
journal = {Cancer Cytopathology},
year = {2026},
volume = {134},
number = {5},
doi = {10.1002/cncy.70101}
}
EUVIMED